Idexx Laboratories IDXX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.1B+3.4% | $1.06B+3.1% | $1.03B+4.2% | $985.66M+10.1% | $894.97M+0.8% | ||
| $148.8M+2.5% | $145.18M+3.6% | $140.17M+1.8% | $137.67M+2.7% | $134.1M+3.2% | ||
| $61.74M+2.9% | $60.01M+3.2% | $58.16M-2.5% | $59.65M-1.4% | $60.51M+0.4% | ||
| $141.15M+7.6% | $131.2M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $9.48M+12.5% | $8.43M+8.5% | $7.77M+3.8% | $7.48M-9.0% | $8.23M+19.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $25.87M+10.4% | $23.43M-16.3% | ||
| —— | —— | —— | —— | —— | ||
| $5.27M+4.8% | $5.03M+36.7% | $3.68M+84.6% | $1.99M+96.3% | $1.02M-30.9% | ||
| $1.21B+2.4% | $1.18B+8.6% | $1.09B+20.1% | $905.81M-6.5% | $968.38M+4.2% | ||
| $126.63M+1.6% | $124.68M+0.1% | $124.5M+2.5% | $121.47M+0.7% | $120.68M-0.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$140.17M-2.9% | -$136.24M+7.9% | -$147.95M-13.4% | -$130.45M-0.6% | -$129.73M+37.3% | ||
| $1.17B-4.1% | $1.22B-0.7% | $1.23B+1.6% | $1.21B+11.3% | $1.08B+29.4% | ||
| $104.33M+11.7% | $93.36M+5.2% | $88.75M+107% | $42.77M+38.8% | $30.81M-30.8% | ||
| $11.67M+61.2% | $7.24M+0.2% | $7.22M-1.8% | $7.36M+13.8% | $6.47M-38.6% | ||
| -$1.05B+10.2% | -$1.16B-11.8% | -$1.04B-2.2% | -$1.02B+4.2% | -$1.06B-21.2% | ||
| —— | —— | —— | $7.36M+194% | -$7.79M+18.2% | ||
| —— | —— | —— | —— | -$237.62M-39.9% | ||
| —— | —— | —— | —— | —— | ||
| $9.48M+12.5% | $8.43M+8.5% | $7.77M+3.8% | $7.48M-9.0% | $8.23M+19.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $104.33M+11.7% | $93.36M+5.2% | $88.75M+107% | $42.77M+38.8% | $30.81M-30.8% | ||
| —— | —— | —— | $329M+373% | $69.5M— | ||
| —— | $250M+33.3% | $187.5M+50.0% | $125M+100% | $62.5M— | ||
| —— | —— | —— | —— | —— | ||
| $3.37M+22.7% | $2.74M+65.7% | $1.66M-3.8% | $1.72M+4.6% | $1.65M+5.6% | ||
| —— | $250M+33.3% | $187.5M+50.0% | $125M+100% | $62.5M— | ||
| $1.08B+2.5% | $1.06B+9.7% | $963.57M+22.9% | $784.34M-7.5% | $847.7M+4.9% | ||
| $1.08B+2.5% | $1.06B+9.7% | $963.57M+22.9% | $784.34M-7.5% | $847.7M+4.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Idexx Laboratories generate?
- Idexx Laboratories (IDXX) generated $1.2B in operating cash flow over the trailing twelve months.
- What is Idexx Laboratories's free cash flow?
- After $126.6M of capital expenditures, Idexx Laboratories's free cash flow was $1.1B over the trailing twelve months, up 27.8% year over year.
- Where does Idexx Laboratories's cash flow data come from?
- Every line is extracted from Idexx Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
